Sheila Gujrathi of Boston, MA appears across SEC filings — Form ADV advisers, Form D, Reg A, and crowdfunding offerings. Sheila Gujrathi appears on 7 filing roles across Form D (6), Form ADV (1).
| Filed | Source | Entity | Role | Location |
|---|---|---|---|---|
| 2025-03-25 | Form ADV | AVALON VENTURES MANAGEMENT, LLC | MEMBER OF ABV SPV I GP, LLC (RELYING ADVISOR) | LA JOLLA, CA |
| 2012-02-17 | Form D | Receptos, Inc. (f.k.a. Receptor Pharmaceuticals Inc.) | Executive Officer | SAN DIEGO, CA |
| 2023-08-10 | Form D | ADARx Pharmaceuticals, Inc. | Director | San Diego, CA |
| 2021-04-30 | Form D | Janux Therapeutics, Inc. | Director | La Jolla, CA |
| 2023-09-28 | Form D | Lila Biologics, Inc. | Director | SEATTLE, WA |
| 2026-04-29 | Form D | SilverArc Private Fund I, LP | Related Person | BOSTON, MA |
| 2024-07-19 | Form D | Prana Therapies, Inc. | Director | ENCINITAS, CA |